Foghorn Therapeutics Inc.
US ˙ NasdaqGM ˙ US3441741077

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Ian F Smith. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Ian F Smith har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SLDB / Solid Biosciences Inc. Director 122.119
US:FHTX / Foghorn Therapeutics Inc. Director 72.072
US:VRTX / Vertex Pharmaceuticals Incorporated EVP, COO 10.625
US:ACOR / Acorda Therapeutics, Inc. Director 15.000
US:INFI / Infinity Pharmaceuticals Inc. Director 4.000
US:OPHT / Ophthotech Corp Director 20.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Ian F Smith. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FHTX / Foghorn Therapeutics Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FHTX / Foghorn Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Insidersalg FHTX / Foghorn Therapeutics Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FHTX / Foghorn Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FHTX / Foghorn Therapeutics Inc. Insider Trades
Insiderkøb INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FHTX / Foghorn Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insidersalg INFIQ / Infinity Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FHTX / Foghorn Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INFIQ / Infinity Pharmaceuticals, Inc. Insider Trades
Insiderkøb SLDB / Solid Biosciences Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FHTX / Foghorn Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SLDB / Solid Biosciences Inc. Insider Trades
Insidersalg SLDB / Solid Biosciences Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FHTX / Foghorn Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SLDB / Solid Biosciences Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Ian F Smith som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-08 2025-07-06 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 4.573 122.119 3,89
2025-04-08 2025-04-06 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 4.574 117.546 4,05
2025-01-07 2025-01-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 3.255 112.972 2,97
2024-10-04 2024-10-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 3.255 109.717 3,06
2024-07-05 2024-07-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 3.255 106.462 3,15
2024-04-05 2024-04-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 3.256 103.207 3,26
2024-01-05 2024-01-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 15.570 99.948 18,45
2023-10-05 2023-10-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 15.569 84.378 22,63
2023-07-06 2023-07-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 15.570 68.809 29,25
2023-06-08 2023-04-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 15.569 53.239 41,33
2023-01-05 2023-01-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 1.620 37.670 4,49
2022-12-05 2022-12-02 4 SLDB Solid Biosciences Inc.
Common Stock
A - Award 13.172 356.380 3,84
2022-10-04 2022-10-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 24.312 343.208 7,62
2022-09-13 3/A FHTX Foghorn Therapeutics Inc.
Common Stock
72.072
2022-07-06 2022-07-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 24.313 318.896 8,25
2022-04-05 2022-04-03 4 SLDB Solid Biosciences Inc.
Restricted Stock Units
M - Exercise -24.313 72.937 -25,00
2022-04-05 2022-04-03 4 SLDB Solid Biosciences Inc.
Common Stock
M - Exercise 24.313 294.583 9,00
2022-01-05 2022-01-03 4 SLDB Solid Biosciences Inc.
Restricted Stock Units
A - Award 97.250 97.250
2022-01-05 2022-01-03 4 SLDB Solid Biosciences Inc.
Director Stock Option (Right to Buy)
A - Award 194.500 194.500
2021-06-24 2021-06-23 4 FHTX Foghorn Therapeutics Inc.
Stock Options (Right to buy)
A - Award 12.530 12.530
2021-06-21 2021-06-16 4 SLDB Solid Biosciences Inc.
Director Stock Option (Right to Buy)
A - Award 30.000 30.000
2021-04-29 3 FHTX Foghorn Therapeutics Inc.
Common Stock
72.072
2021-04-29 2021-04-27 4 FHTX Foghorn Therapeutics Inc.
Stock Options (Right to buy)
A - Award 25.060 25.060 11,50 288.190 288.190
2021-01-06 2021-01-04 4 SLDB Solid Biosciences Inc.
Stock Option (Right to Buy)
A - Award 389.000 389.000
2020-12-14 2020-12-10 4 SLDB Solid Biosciences Inc.
Common Stock
A - Award 270.270 270.270 3,70 999.999 999.999
2020-06-18 2020-06-16 4 SLDB Solid Biosciences Inc.
Director Stock Option (Right to Buy)
A - Award 200.000 200.000
2020-04-16 2020-04-15 4 SLDB Solid Biosciences Inc.
Director Stock Option (Right to Buy)
A - Award 40.000 40.000
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -23.375 10.625 -68,75
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -18.634 46.699 -28,52 166,57 -3.103.865 7.778.652
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.741 65.333 -6,77 165,22 -783.308 10.794.318
2018-07-03 2018-06-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 23.375 70.074 50,05 131,89 3.082.929 9.242.060
2018-06-29 2018-06-27 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -4.250 12.750 -25,00
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.250 46.699 -8,34 160,00 -680.000 7.471.840
2018-06-26 2018-06-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.250 50.949 9,10 109,14 463.845 5.560.574
2018-06-19 2018-06-15 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -15.000 0 -100,00
2018-06-19 2018-06-15 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -10.000 0 -100,00
2018-06-19 2018-06-15 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -25.000 0 -100,00 31,42 -785.568
2018-06-19 2018-06-15 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 15.000 25.000 150,00 13,80 207.000 345.000
2018-06-19 2018-06-15 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 10.000 10.000 25,45 254.500 254.500
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2018-06-14 2018-06-12 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 22.857 45.845 99,43 1,75 40.000 80.229
2018-05-16 2018-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -217 46.699 -0,46 155,78 -33.804 7.274.770
2018-05-15 2018-05-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.941 21.358 -8,33
2018-05-15 2018-05-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.155 15.086 -12,50
2018-05-15 2018-05-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.096 46.699 -8,06 155,00 -634.880 7.238.345
2018-05-15 2018-05-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.941 50.795 3,97 86,52 167.935 4.394.783
2018-05-15 2018-05-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.155 48.854 4,61 91,05 196.213 4.448.157
2018-05-04 2018-05-02 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -10.000 0 -100,00
2018-05-04 2018-05-02 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -6.323 0 -100,00 23,86 -150.897
2018-05-04 2018-05-02 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -3.677 6.323 -36,77 23,46 -86.277 148.364
2018-05-04 2018-05-02 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 10.000 10.000 20,16 201.600 201.600
2018-04-27 2018-04-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy
M - Exercise -51.000 17.000 -75,00
2018-04-27 2018-04-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy
M - Exercise -2.125 2.125 -50,00
2018-04-27 2018-04-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -53.125 46.699 -53,22 160,12 -8.506.375 7.477.444
2018-04-27 2018-04-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 51.000 99.824 104,46 109,14 5.566.140 10.894.791
2018-04-27 2018-04-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.125 48.824 4,55 96,87 205.849 4.729.581
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy
M - Exercise -7.766 23.299 -25,00
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy
M - Exercise -2.156 17.241 -11,12
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy
M - Exercise -4.250 0 -100,00
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.700 46.699 -5,47 156,78 -423.306 7.321.469
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.790 49.399 -16,54 155,62 -1.523.520 7.687.472
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19.478 59.189 -24,76 154,98 -3.018.700 9.173.111
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.766 78.667 10,95 86,52 671.914 6.806.269
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.156 70.901 3,14 91,05 196.304 6.455.536
2018-04-27 2018-04-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.250 68.745 6,59 77,31 328.568 5.314.676
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 19.566 19.566
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 8.437 64.495 15,05
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 15.170 56.058 37,10
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.125 4.250 -33,33
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 40.888 -1,21 159,29 -79.645 6.513.050
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 41.388 -0,96 158,11 -63.244 6.543.857
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 41.788 -0,95 157,02 -62.808 6.561.552
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -825 42.188 -1,92 155,80 -128.535 6.572.890
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -2.125 43.013 -4,71 96,87 -205.849 4.166.669
2017-11-17 2017-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7 40.888 -0,02 147,29 -1.031 6.022.394
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -4.250 4.250 -50,00
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.250 40.888 -9,42 150,00 -637.500 6.133.200
2017-11-07 2017-11-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.250 45.138 10,39 77,31 328.568 3.489.619
2017-11-07 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.155 19.397 -10,00
2017-11-07 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.155 40.888 -5,01 150,00 -323.250 6.133.200
2017-11-07 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.155 43.043 5,27 91,05 196.213 3.919.065
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 40.888 -0,49 149,34 -29.868 6.106.214
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.791 41.088 -8,45 148,26 -562.054 6.091.707
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.500 44.879 -7,23 147,40 -515.900 6.615.165
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.200 48.379 -9,71 146,39 -761.228 7.082.202
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -22.464 53.579 -29,54 145,26 -3.263.121 7.782.886
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -32.945 76.043 -30,23 144,47 -4.759.564 10.985.932
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.200 108.988 -4,55 143,47 -746.044 15.636.508
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.700 114.188 -1,47 142,40 -242.080 16.260.371
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.125 6.375 -25,00
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 115.888 -0,17 157,07 -31.414 18.202.528
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -850 116.088 -0,73 156,24 -132.804 18.137.589
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -875 116.938 -0,74 155,03 -135.651 18.128.898
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 117.813 -0,17 154,01 -30.802 18.144.380
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.125 118.013 1,83 96,87 205.849 11.431.919
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -4.250 8.500 -33,33
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.250 115.888 -1,07 156,02 -195.025 18.080.846
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.600 117.138 -2,17 155,29 -403.754 18.190.360
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 119.738 -0,33 154,09 -61.636 18.450.428
2017-08-09 2017-08-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.250 120.138 3,67 77,31 328.568 9.287.869
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.155 21.552 -9,09
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -455 115.888 -0,39 156,09 -71.021 18.088.958
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 116.343 -0,60 154,55 -108.185 17.980.811
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 117.043 -0,43 153,57 -76.785 17.974.294
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 117.543 -0,42 152,49 -76.245 17.924.132
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.155 118.043 1,86 91,05 196.213 10.747.815
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.125 0 -100,00
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 115.888 -0,09 154,13 -15.413 17.861.817
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 115.988 -0,94 153,30 -168.630 17.780.960
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -925 117.088 -0,78 152,24 -140.822 17.825.477
2017-08-02 2017-07-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.125 118.013 1,83 83,36 177.140 9.837.564
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 115.888 -0,17 162,40 -32.480 18.820.211
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.106 116.088 -4,21 161,71 -825.691 18.772.590
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.000 121.194 -1,62 161,01 -322.020 19.513.446
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -815 123.194 -0,66 159,61 -130.082 19.662.994
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.829 124.009 -1,45 158,62 -290.116 19.670.308
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 125.838 -0,32 157,56 -63.024 19.827.035
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -31.875 2.125 -93,75
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -55.250 12.750 -81,25
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.775 23.707 -31,25
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -25.500 8.500 -75,00
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -123.400 126.238 -49,43 161,00 -19.867.400 20.324.318
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 31.875 249.638 14,64 83,36 2.657.100 20.809.824
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 55.250 217.763 34,00 77,31 4.271.378 16.835.258
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.775 162.513 7,10 91,05 981.064 14.796.809
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 25.500 151.738 20,20 96,87 2.470.185 14.698.860
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -10.195 0 -100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -9.062 0 -100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -23.789 0 -100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -18.124 0 -100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -37.383 0 -100,00
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -98.553 126.238 -43,84 124,00 -12.220.572 15.653.512
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.195 224.791 4,75 38,80 395.566 8.721.891
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 9.062 214.596 4,41 51,75 468.958 11.105.343
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 23.789 205.534 13,09 37,86 900.652 7.781.517
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 18.124 181.745 11,08 48,74 883.364 8.858.251
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 37.383 163.621 29,61 45,11 1.686.347 7.380.943
2017-06-02 2017-05-31 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2017-05-26 2017-05-25 4 INFI INFINITY PHARMACEUTICALS, INC.
Common Stock
A - Award 22.988 22.988 1,74 39.999 39.999
2017-05-17 2017-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -294 126.238 -0,23 114,92 -33.786 14.507.271
2017-03-02 2017-02-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.842 126.238 -2,95 90,00 -345.780 11.361.420
2017-02-15 2017-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.842 130.080 -2,87 87,66 -336.790 11.402.813
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 31.065 31.065
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 15.170 133.922 12,77
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 5.753 118.752 5,09 0,01 58 1.188
2017-01-09 2017-01-06 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40.000 40.000
2016-08-04 2016-08-02 4 OPHT Ophthotech Corp.
Stock Option (Right to Buy)
A - Award 20.000 20.000
2016-06-21 2016-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2016-06-21 2016-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 20.000 20.000
2016-06-10 2016-06-08 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2016-05-18 2016-05-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -202 112.999 -0,18 82,06 -16.576 9.272.698
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.652 112.999 -1,44 92,73 -153.190 10.478.397
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 114.651 -1,04 91,68 -110.016 10.511.204
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.232 115.851 -3,52 90,97 -384.985 10.538.965
2016-02-04 2016-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.000 120.083 -4,00 89,90 -449.500 10.795.462
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 34.482 34.482
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 17.299 125.083 16,05 0,01 173 1.251
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -10.000 0 -100,00
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -2.689 0 -100,00
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
M - Exercise X -542 0 -100,00
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -100 0 -100,00 42,26 -4.226
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
S - Sale X -13.131 100 -99,24 41,85 -549.480 4.185
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 10.000 13.231 309,50 18,21 182.100 240.937
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 2.689 3.231 496,13 17,85 47.999 57.673
2016-01-06 2016-01-04 4 ACOR ACORDA THERAPEUTICS INC
Common Stock
M - Exercise X 542 542 22,13 11.994 11.994
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.685 107.784 -2,43 126,62 -339.975 13.647.610
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.865 110.469 -4,22 125,98 -612.893 13.916.885
2015-11-03 2015-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.800 115.334 -2,37 124,95 -349.860 14.410.983
2015-07-23 2015-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 34.000 34.000
2015-06-16 2015-06-15 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2015-06-16 2015-06-15 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2015-06-11 2015-06-09 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 15.000 15.000
2015-05-18 2015-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 118.134 -0,08 126,99 -12.699 15.001.837
2015-05-18 2015-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -178 118.234 -0,15 125,84 -22.400 14.878.567
2015-05-18 2015-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 118.412 -0,08 123,85 -12.385 14.665.326
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 118.134 -0,42 127,83 -63.915 15.101.069
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.000 118.634 -0,84 126,65 -126.650 15.024.996
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.815 119.634 -2,30 125,69 -353.817 15.036.797
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.327 122.449 -1,07 124,87 -165.702 15.290.207
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 123.776 -0,16 123,52 -24.704 15.288.812
2015-03-24 2015-03-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 123.976 -0,16 122,44 -24.488 15.179.621
2015-02-20 2015-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.100 124.176 -3,95 113,13 -576.963 14.048.031
2015-02-20 2015-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.250 129.276 -3,90 112,66 -591.465 14.564.234
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
A - Award 68.000 68.000
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.700 134.526 18,19 0,01 207 1.345
2014-12-16 2014-12-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.880 113.826 -2,47 120,44 -346.867 13.709.203
2014-12-16 2014-12-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.162 116.706 -2,64 119,82 -378.871 13.983.713
2014-11-03 2014-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 75.000 119.868 167,16 0,01 750 1.199
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -16.992 37.383 -31,25
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -18.126 18.124 -50,00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -16.993 23.789 -41,67
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -16.993 23.789 -41,67
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -11.330 9.062 -55,56
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -11.329 0 -100,00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -13.594 0 -100,00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -2.267 0 -100,00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -22.156 44.868 -33,06 113,90 -2.523.568 5.110.465
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -28.751 67.024 -30,02 113,10 -3.251.738 7.580.414
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -43.112 95.775 -31,04 112,21 -4.837.598 10.746.913
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -14.007 138.887 -9,16 111,31 -1.559.119 15.459.512
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 16.992 152.894 12,50 45,11 766.509 6.897.048
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 18.126 135.902 15,39 48,74 883.461 6.623.863
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 16.993 117.776 16,86 37,86 643.355 4.458.999
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.330 100.783 12,67 51,75 586.328 5.215.520
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 16.993 89.453 23,45 38,80 659.328 3.470.776
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 11.329 72.460 18,53 33,82 383.147 2.450.597
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 13.594 61.131 28,60 39,05 530.846 2.387.166
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.267 47.537 5,01 33,28 75.446 1.582.031
2014-07-17 2014-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 34.000 34.000
2014-06-19 2014-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2014-06-19 2014-06-17 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2014-06-09 2014-06-05 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 68.000 68.000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.700 44.868 85,65 0,01 207 449
2013-08-01 2013-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34.000 34.000
2013-06-13 2013-06-11 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2013-06-13 2013-06-11 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15.000 15.000
2013-06-03 2013-05-30 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2013-05-17 2013-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 24.168 -0,41 80,50 -8.050 1.945.524
2013-05-17 2013-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -509 24.268 -2,05 79,51 -40.471 1.929.549
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -13.593 40.782 -25,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -15.858 20.392 -43,75
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -27.187 27.188 -50,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -24.921 11.329 -68,75
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy
M - Exercise -40.781 13.594 -75,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -300.000 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -33.983 2.267 -93,75
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -54.375 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -54.375 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -36.250 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -36.250 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -28.570 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -73.500 0 -100,00
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -54.367 24.168 -69,23 85,00 -4.621.195 2.054.280
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -691.318 78.535 -89,80 81,50 -56.342.417 6.400.602
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 13.593 769.853 1,80 37,86 514.631 29.146.635
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 300.000 756.260 65,75 33,00 9.900.000 24.956.580
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 73.500 456.260 19,20 35,64 2.619.540 16.261.106
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 36.250 382.760 10,46 32,16 1.165.800 12.309.562
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 28.570 346.510 8,99 28,84 823.959 9.993.348
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 54.375 317.940 20,63 36,30 1.973.812 11.541.222
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 36.250 263.565 15,95 35,35 1.281.438 9.317.023
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 33.983 227.315 17,58 33,28 1.130.954 7.565.043
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 54.375 193.332 39,13 33,55 1.824.281 6.486.289
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 40.781 138.957 41,54 39,05 1.592.498 5.426.271
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 24.921 98.176 34,02 33,82 842.828 3.320.312
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 27.187 73.255 59,01 38,80 1.054.856 2.842.294
2013-04-23 2013-04-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 15.858 46.068 52,49 51,75 820.652 2.384.019
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 54.375 54.375
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.084 30.210 66,67 0,01 121 302
2012-11-20 2012-11-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.042 18.126 -25,00 41,26 -249.293 747.879
2012-10-15 2012-10-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -6.363 0 -100,00
2012-10-15 2012-10-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -7.680 28.570 -21,19
2012-10-15 2012-10-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -14.043 24.168 -36,75 60,00 -842.580 1.450.080
2012-10-15 2012-10-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.363 38.211 19,98 18,93 120.452 723.334
2012-10-15 2012-10-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.680 31.848 31,78 28,84 221.491 918.496
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -7.875 0 -100,00
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -29.887 6.363 -82,45
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
M - Exercise -6.187 0 -100,00
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -44.787 24.168 -64,95 60,00 -2.687.220 1.450.080
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7.875 68.955 12,89 17,16 135.135 1.183.268
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 29.887 61.080 95,81 18,93 565.761 1.156.244
2012-10-09 2012-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.187 31.193 24,74 10,41 64.407 324.719
2012-07-26 2012-07-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 36.250 36.250
2012-06-07 2012-06-06 4 ACOR ACORDA THERAPEUTICS INC
Non-Employee Stock Option
A - Award 10.000 10.000
2012-05-18 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2012-05-18 2012-05-16 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 6.000 6.000
2012-02-09 2012-02-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9.667 24.168 -28,57 36,80 -355.746 889.382
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 54.375 54.375
2012-02-06 2012-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.084 33.835 55,56 0,01 121 338
2012-01-23 2012-01-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6.042 21.751 -21,74 37,00 -223.554 804.787
2011-11-16 2011-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20 27.793 -0,07 29,75 -595 826.842
2011-05-19 2011-05-18 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4.000 4.000
2011-05-19 2011-05-18 4 INFI INFINITY PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 6.000 6.000
2007-02-05 3 ACOR ACORDA THERAPEUTICS INC
No securities are beneficially owned.
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)